Jenny Ming
About Jenny Ming
Independent director at Levi Strauss & Co. since 2014, Jenny Ming is a retail operator with deep apparel, DTC and omnichannel expertise; she currently serves as CEO and Director of Rothy’s, Inc. (since January 2024) and previously led Old Navy as its first President and Charlotte Russe as CEO . She serves on LEVI’s Compensation & Human Capital Committee and Nominating, Governance & Corporate Citizenship Committee; committee memberships are limited to independent directors under LEVI’s governance framework, and CHCC members meet NYSE/SEC independence standards . In FY2024 the Board held six meetings and each director attended at least 75% of Board and assigned committee meetings; executive sessions of non‑management directors occur at every Board meeting under an independent Board Chair structure . She is a Class II director with a term through the 2027 annual meeting; age 69 per the 2025 proxy .
Past Roles
| Organization | Role | Tenure | Committees/Impact |
|---|---|---|---|
| Rothy’s, Inc. | Chief Executive Officer; Director | CEO since Jan 2024; Director since Jun 2022 | CEO of sustainable shoes/handbags/accessories retailer |
| Charlotte Russe Inc. | President & CEO | Oct 2009 – Feb 2019 | Company filed for Chapter 11 in Feb 2019 (context on turnaround/financial stress) |
| Old Navy (Gap Inc.) | First President | Mar 1999 – Oct 2006 | Member of Gap Inc. exec team that launched Old Navy; scaled to ~$7B brand; oversaw ~900 stores in U.S./Canada |
| Gap Inc. | Various executive roles | 1986 – 1999 | Executive capacities at San Francisco HQ |
External Roles
| Organization | Role | Tenure | Notes |
|---|---|---|---|
| Kaiser Foundation Hospital and Health Plan | Director | Not disclosed | Non-profit healthcare system governance role |
| Kendra Scott, LLC | Former Director | Not disclosed | Private company board experience |
| Affirm Holdings, Inc. | Former Director | Not disclosed | Prior public company board service |
| Poshmark, Inc. | Former Director | Not disclosed | Prior public company board service |
Board Governance
| Attribute | Detail |
|---|---|
| Committees | Compensation & Human Capital Committee (member); Nominating, Governance & Corporate Citizenship Committee (member) |
| Committee meetings (FY2024) | CHCC: 4 meetings; NGCCC: 5 meetings |
| Board meetings/attendance | Board met 6 times; each director attended ≥75% of Board and assigned committee meetings |
| Independence | CHCC composition meets NYSE/SEC independence; committee membership limited to independent directors per governance practices |
| Board leadership | Independent Board Chair structure (Robert Eckert) with executive sessions at every Board meeting |
| Director class/term | Class II; term ends at 2027 annual meeting |
| Annual meeting attendance | All then‑serving directors attended the 2024 annual meeting |
Fixed Compensation
| Component (FY2024) | Amount ($) |
|---|---|
| Annual cash retainer | 100,000 |
| Committee chair fees | 0 (not a chair) |
| All other compensation (dividend-equivalent RSUs) | 12,727 |
Director fee schedule: $100,000 cash retainer; committee chair retainers—Audit $25,000; CHCC $20,000; Finance $15,000; NGCCC $15,000 .
Performance Compensation
| Element | Terms / FY2024 Facts |
|---|---|
| Annual RSU award (program value) | $155,000 program value in FY2024; increased to $175,000 beginning FY2025 |
| Grant mechanics | Number of RSUs = program value ÷ 20‑trading‑day avg stock price leading up to grant date |
| Vesting schedule | Vests in full at earlier of day before next annual meeting or one‑year anniversary; initial grants generally deferred until six months after Board service ends |
| Dividend equivalents | Additional RSUs granted as dividend equivalents when dividends are declared; subject to same vesting terms |
| FY2024 grant date fair value (actual reported) | $164,838 in stock awards (grant date fair value) |
Note: Non‑employee director equity is time‑based; no performance metrics (TSR/EBITDA, etc.) are tied to director equity awards per program description .
Other Directorships & Interlocks
| Item | Detail |
|---|---|
| Current external boards | Rothy’s, Inc.; Kaiser Foundation Hospital and Health Plan |
| Prior external boards | Kendra Scott, LLC; Affirm Holdings, Inc.; Poshmark, Inc. |
| CHCC interlocks | None—no Compensation & Human Capital Committee interlocks in FY2024 |
Expertise & Qualifications
- Extensive operational and retail leadership experience in the apparel industry; Old Navy brand builder and scaled operator .
- CEO experience at Rothy’s (sustainable DTC footwear/accessories); omnichannel and merchandising expertise .
- Governance experience via service on NGCCC overseeing nominations, governance practices and corporate citizenship/sustainability .
Equity Ownership
| Metric | Amount |
|---|---|
| Class A shares beneficially owned | 44,730 (<1% of Class A) |
| Class B shares beneficially owned | 43,563 (<1% of Class B) |
| Aggregate outstanding RSUs (as of Dec 1, 2024) | 44,248 (includes vested but deferred and unvested RSUs) |
| Ownership guidelines | 5× annual retainer ($500,000) within 5 years; all current directors in compliance as of Dec 1, 2024 |
Governance Assessment
-
Strengths:
- Independent director serving on CHCC and NGCCC, with committees meeting NYSE/SEC independence standards; independent Chair structure and executive sessions at every Board meeting bolster oversight .
- Solid engagement: Board met six times in FY2024 with ≥75% attendance by each director; all directors attended the 2024 annual meeting .
- Alignment: Meaningful equity component via annual RSUs; directors meet stock ownership guidelines (≥$500,000 within five years; all in compliance as of Dec 1, 2024). FY2025 equity award increase further tilts mix to equity .
-
Oversight and potential conflicts:
- As CEO of Rothy’s (apparel/footwear), Ms. Ming operates in an adjacent industry; LEVI’s Related Party Transaction Policy requires NGCCC review/Board approval of any transactions involving directors or related persons, providing a control for potential conflicts .
-
RED FLAGS / Watch items:
- Charlotte Russe Chapter 11 filing in Feb 2019 during Ms. Ming’s CEO tenure—relevant context for turnaround/risk experience rather than a current conflict, but notable for investor diligence .